Britain | Quotient Therapeutics

What a buzzy startup reveals about Britain’s biotech sector

Lots of clever scientists, not enough business nous

Sculpture by Charles Jencks of DNA double helix Cambridge University.
Photograph: Alamy
|GREAT CHESTERFORD

Over the past century, two breakthroughs have changed the course of biology most. Both were Anglo-American efforts, propelled by Cambridge laboratories. First came the unravelling of the double helix by scientists including James Watson (an American) and Francis Crick (a Brit). Then came the Human Genome Project, which mapped the genetic code that acts as an instruction manual for human beings. That project was led by Americans, but the largest contribution came from Cambridge’s Sanger Institute, which sequenced a third of the billions of letters of code. These advances transformed the way scientists understand disease.

Explore more

This article appeared in the Britain section of the print edition under the headline “Cambridge lessons”

From the January 25th 2025 edition

Discover stories from this section and more in the list of contents

Explore the edition

More from Britain

Stock price information displayed on a board at the London Stock Exchange.

Britain’s brokers are diversifying and becoming less British

London’s depleted stockmarket is forcing them to change

Illustration of Kier Starmer facing away next to the stripes of the Union Jack and the stars of the EU flag

Britain’s government lacks a clear Europe policy

It should be more ambitious over getting closer to the EU


Rachel Reeves at the World Economist Forum in Davos, Switzerland

The Rachel Reeves theory of growth

The chancellor says it’s her number-one priority. We ask her what that means for Britain


What an arcane piece of aviation law says about Britain’s government

The parable of the slots

London’s pie-and-mash shops are disappearing

Blame higher rents and changing tastes